Novartis AG ADR (NVS): Price and Financial Metrics

Novartis AG ADR (NVS): $85.85

-0.25 (-0.29%)

POWR Rating

Component Grades














  • NVS scores best on the Stability dimension, with a Stability rank ahead of 98.82% of US stocks.
  • NVS's strongest trending metric is Growth; it's been moving down over the last 177 days.
  • NVS's current lowest rank is in the Growth metric (where it is better than 17.08% of US stocks).

NVS Stock Summary

  • With a market capitalization of $182,498,339,808, NOVARTIS AG has a greater market value than 99.05% of US stocks.
  • In terms of volatility of its share price, NVS is more volatile than just 8.34% of stocks we're observing.
  • NOVARTIS AG's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 11.3%, greater than the shareholder yield of 86.56% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to NOVARTIS AG are AZN, BMY, RTX, TXN, and NFLX.
  • Visit NVS's SEC page to see the company's official filings. To visit the company's web site, go to

NVS Valuation Summary

  • In comparison to the median Healthcare stock, NVS's price/sales ratio is 27.45% lower, now standing at 3.7.
  • NVS's price/sales ratio has moved down 1.8 over the prior 243 months.

Below are key valuation metrics over time for NVS.

Stock Date P/S P/B P/E EV/EBIT
NVS 2023-01-30 3.7 3.2 8.9 8.8
NVS 2023-01-27 3.7 3.2 8.9 8.8
NVS 2023-01-26 3.7 3.2 8.9 8.8
NVS 2023-01-25 3.8 3.3 9.2 9.1
NVS 2023-01-24 3.8 3.3 9.1 9.0
NVS 2023-01-23 3.8 3.3 9.2 9.0

NVS Growth Metrics

    The 5 year cash and equivalents growth rate now stands at -45.03%.
  • The 3 year revenue growth rate now stands at 2.52%.
  • Its year over year cash and equivalents growth rate is now at 264.43%.
NVS's revenue has moved up $2,852,000,000 over the prior 67 months.

The table below shows NVS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 52,263 14,009 21,797
2022-06-30 52,788 14,213 22,982
2022-03-31 52,997 14,590 24,184
2021-12-31 52,877 15,071 24,021
2021-09-30 52,385 15,192 9,807
2021-06-30 51,556 13,423 8,984

NVS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • NVS has a Quality Grade of B, ranking ahead of 86.01% of graded US stocks.
  • NVS's asset turnover comes in at 0.42 -- ranking 108th of 682 Pharmaceutical Products stocks.
  • GHSI, KALA, and ADAP are the stocks whose asset turnover ratios are most correlated with NVS.

The table below shows NVS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.420 0.693 0.212
2021-06-30 0.406 0.691 0.194
2021-03-31 0.393 0.691 0.176
2020-12-31 0.392 0.697 0.182
2020-09-30 0.401 0.700 0.174
2020-06-30 0.412 0.699 0.180

NVS Stock Price Chart Interactive Chart >

Price chart for NVS

NVS Price/Volume Stats

Current price $85.85 52-week high $94.26
Prev. close $86.10 52-week low $74.09
Day low $85.58 Volume 3,891,200
Day high $86.69 Avg. volume 2,346,787
50-day MA $90.44 Dividend yield 2.52%
200-day MA $85.21 Market Cap 189.95B

Novartis AG ADR (NVS) Company Bio

Novartis AG is a Swiss-American multinational pharmaceutical corporation based in Basel, Switzerland and Cambridge, MassachusettsUnited States (global research). It is one of the largest pharmaceutical companies in the world. (Source:Wikipedia)

NVS Latest News Stream

Event/Time News Detail
Loading, please wait...

NVS Latest Social Stream

Loading social stream, please wait...

View Full NVS Social Stream

Latest NVS News From Around the Web

Below are the latest news stories about NOVARTIS AG that investors may wish to consider to help them evaluate NVS as an investment opportunity.

Novartis (VTX:NOVN) Is Paying Out A Larger Dividend Than Last Year

Novartis AG's ( VTX:NOVN ) dividend will be increasing from last year's payment of the same period to $3.20 on 13th of...

Yahoo | February 4, 2023

Patients with hidradenitis suppurativa experienced sustained efficacy and symptom improvement at one year when treated with Novartis Cosentyx®

In two of the largest Phase III trials conducted in hidradenitis suppurativa (HS), Cosentyx® (secukinumab) treatment response rates continued to improve beyond the primary endpoint analysis at Week 16 to more than 55% at Week 52, as evaluated by the HS Clinical Response (HiSCR) measure1 Safety findings were consistent with the well-established safety profile of Cosentyx in its approved indications1 HS is a recurrent skin disease affecting one in 100 people worldwide, causing painful, boil-like a

Yahoo | February 3, 2023

Novartis Full Year 2022 Earnings: Misses Expectations

Novartis ( VTX:NOVN ) Full Year 2022 Results Key Financial Results Revenue: US$51.8b (down 2.0% from FY 2021). Net...

Yahoo | February 3, 2023

Novartis AG (NYSE:NVS) Q4 2022 Earnings Call Transcript

Novartis AG (NYSE:NVS) Q4 2022 Earnings Call Transcript February 1, 2023 Operator: Good morning and good afternoon, and welcome to the Novartis Q4 2022 Results Release Conference Call and Live Webcast. Please note that during the presentation all participants will be in a listen-only mode and the conference is being recorded. After the presentation, there […]

Yahoo | February 2, 2023

Over dinner in Davos, the CEOs of Novartis, Coca-Cola, and Grab shared what’s worrying them

Highlights from Fortune's dinner in Davos.

Yahoo | February 1, 2023

Read More 'NVS' Stories Here

NVS Price Returns

1-mo -6.98%
3-mo 4.94%
6-mo -1.49%
1-year 2.14%
3-year -4.69%
5-year 28.89%
YTD -5.37%
2022 6.47%
2021 -5.12%
2020 2.08%
2019 28.03%
2018 5.95%

NVS Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full NVS Dividend History

Continue Researching NVS

Want to see what other sources are saying about Novartis Ag's financials and stock price? Try the links below:

Novartis Ag (NVS) Stock Price | Nasdaq
Novartis Ag (NVS) Stock Quote, History and News - Yahoo Finance
Novartis Ag (NVS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6579 seconds.